Filters

Brimonidine manufacturers

34 products found

Filters

brimonidine

Eye drops 2mg/ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
Sweden, Norway

brimonidine

Eye drops 0.2% - 5ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP

brimonidine + timolol

Eye drops 0.2 % + 0.5 %

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP
Unavailable markets
Vietnam

brimonidine

Eye drops 0.20 %

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP
Unavailable markets
Vietnam

brimonidine

Eye drops 2mg/ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP
Unavailable markets
Vietnam

brimonidine + timolol

Eye drops (2mg+5mg)/ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Under Development
GMP approvals
EU GMP
Unavailable markets
Vietnam

brimonidine

Eye drops 0,2% (2,5, 5, 10ml)

Dossier type
EU CTD
Country of origin
India
Dossier status
Ready
GMP approvals
EU GMP
Unavailable markets
Australia, New Zealand

brimonidine + timolol

Eye drops 2mg/ml+5mg/ml 5ml

Dossier type
EU CTD
Country of origin
Ukraine
Dossier status
Ready
GMP approvals
EU GMP

brimonidine + timolol

Eye drops 0.2%+0.5% (5ml, 10ml)

Dossier type
EU CTD
Country of origin
India
Dossier status
Ready
GMP approvals
EU GMP

brimonidine

Eye drops 2 mg/ml

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Under Development
GMP approvals
EU GMP

BRIMONIDINE Manufacturers and Suppliers

We have found 47 verified brimonidine manufacturers and brimonidine suppliers from our global list of sellers. The pharmaceutical drug is available for sale in different forms such as eye drops, ointment, the ophthalmic solutions from manufacturers in various countries including India, European Union, Colombia.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of brimonidine offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for brimonidine manufacturers and brimonidine suppliers that you are looking for. These also enable you to check the dossier status of brimonidine, and the GMP approvals of the different variants of brimonidine. Also, each manufacturer or supplier product description contains essential information about brimonidine-including clinical data, stability zones, countries where brimonidine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over brimonidine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that brimonidine manufacturers have, we qualify their companies before they are on-boarded on the platform. This allows us to screen brimonidine manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.